Literature DB >> 3352882

Spinal fixation after anterior decompression for symptomatic spinal metastasis.

R G Perrin1, R J McBroom.   

Abstract

Surgical strategies for the treatment of symptomatic spinal metastases must take into account both decompression of the spinal cord and stabilization of the spinal column. A method is described for securing spinal stabilization in patients who have undergone surgical decompression for symptomatic spinal metastases by an anterior approach. The fixation device used is a tailor-made prosthesis consisting of a U-shaped stainless steel plate permitting screw fixation to secure axial and rotational stability with an interposed methyl methacrylate strut to provide axial strength and support. The device has been used successfully in 51 patients who have undergone anterior decompression procedures for symptomatic spinal metastases.

Entities:  

Mesh:

Year:  1988        PMID: 3352882     DOI: 10.1227/00006123-198802000-00008

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  4 in total

Review 1.  Cervical spine metastases: techniques for anterior reconstruction and stabilization.

Authors:  Christina M Sayama; Meic H Schmidt; Erica F Bisson
Journal:  Neurosurg Rev       Date:  2012-04-29       Impact factor: 3.042

2.  Prognostic factors in anterior decompression for metastatic cord compression. An analysis of results.

Authors:  E Sucher; J Y Margulies; Y Floman; G C Robin
Journal:  Eur Spine J       Date:  1994       Impact factor: 3.134

Review 3.  Metastatic epidural spinal cord compression: current concepts and treatment.

Authors:  R Grant; S M Papadopoulos; H M Sandler; H S Greenberg
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

4.  Prevalence of known and unknown primary tumor sites in spinal metastasis patients.

Authors:  Permsak Paholpak; Winai Sirichativapee; Taweechok Wisanuyotin; Weerachai Kosuwon; Polasak Jeeravipoolvarn
Journal:  Open Orthop J       Date:  2012-10-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.